January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
Based on market forecasts, the sports herbal supplements sector will expand from USD 2.42 billion in 2024 to USD 4.42 billion by 2034, experiencing a CAGR of 6.54%. The sports herbal supplements market is growing as it enhances endurance and stamina, improves strength and recovery, stress reduction and mental focus, energy levels, and metabolism. N...
November 01, 2025
Market insights predict the global drug-loaded fat emulsion industry will increase from USD 2.34 billion in 2024 to USD 7.25 billion by 2034, achieving a CAGR of 12.04%. The principal advantages of these delivery systems, including versatile administration routes, drive the growth of drug-loaded fat emulsions. North America dominated the market in ...
November 01, 2025
According to market projections, the steroid hormone API sector is expected to grow from USD 3.54 billion in 2024 to USD 6.06 billion by 2034, reflecting a CAGR of 5.54%. The steroid hormone API market is growing due to rising demand for natural steroids. Europe is dominating the market due to the rising production of various natural and synthetic ...
November 01, 2025
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing demand for personalized medicines bolster market growth. North America dominated the global market d...
November 01, 2025
Projections indicate that, the global diabetes medicines market will increase from USD 109.38 billion in 2024 to USD 326.37 billion by 2034, experiencing a CAGR of 11.24% over the next 10 years. The diabetes medicines market is expanding due to an unhealthy lifestyle as well as the rising adoption of combination therapies. North America led the mar...
November 01, 2025
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimated to drive the growth of the market in the near future. The national health systems and tender-based...
November 01, 2025
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of diabetes and growing research and development activities bolster market growth. North America led the...
November 01, 2025
Market insights predict, the compound management industry is expected to grow from USD 492.14 million in 2024 to USD 1899.41 million by 2034, driven by a CAGR of 14.51%. The compound management market is expanding due to growing outsourcing trends, as well as increasing clinical trials. North America led the market due to the presence of huge...
November 01, 2025
Based on market forecasts, the U.S. Controlled Substance market, projected at USD 52.3 billion in 2024, is expected to reach USD 84.95 billion by 2034, growing at a CAGR of 5.24% over the forecast period. The U.S. Controlled Substance Market is growing because these substances extend throughout manufacture, use, handling, distribution, and storage....
November 01, 2025
According to market projections, the global albumin pharma market, valued at USD 6.77 billion in 2024, is anticipated to reach USD 11.72 billion by 2034, growing at a CAGR of 5.65% over the next decade. The rising prevalence of chronic diseases such as liver cirrhosis, kidney disorders, and cardiovascular conditions increases demand for albumin-bas...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com